These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 37391097)
21. Thrombin generation in the presence of platelets is sensitive to the activation status of von Willebrand factor. Pelkmans L; Miszta A; Al Dieri R; de Laat B; Kelchtermans H Thromb Haemost; 2015 Jan; 113(1):209-11. PubMed ID: 25274249 [No Abstract] [Full Text] [Related]
22. Thrombin and protease-activated receptors (PARs) in atherothrombosis. Martorell L; Martínez-González J; Rodríguez C; Gentile M; Calvayrac O; Badimon L Thromb Haemost; 2008 Feb; 99(2):305-15. PubMed ID: 18278179 [TBL] [Abstract][Full Text] [Related]
23. Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis. Pawlinski R; Mackman N Crit Care Med; 2004 May; 32(5 Suppl):S293-7. PubMed ID: 15118533 [TBL] [Abstract][Full Text] [Related]
27. Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Pawlinski R; Pedersen B; Schabbauer G; Tencati M; Holscher T; Boisvert W; Andrade-Gordon P; Frank RD; Mackman N Blood; 2004 Feb; 103(4):1342-7. PubMed ID: 14576054 [TBL] [Abstract][Full Text] [Related]
28. Hydrolysis of human platelet membrane glycoproteins with a Serratia marcescens metalloprotease: effect on response to thrombin and von Willebrand factor. Cooper HA; Bennett WP; White GC; Wagner RH Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1433-7. PubMed ID: 7041120 [TBL] [Abstract][Full Text] [Related]
29. Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking. Beckman JD; Holle LA; Wolberg AS J Thromb Haemost; 2018 Jan; 16(1):131-141. PubMed ID: 29080382 [TBL] [Abstract][Full Text] [Related]
30. Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19. Busch MH; Timmermans SAMEG; Van Kuijk SMJ; Aendekerk JP; Ysermans R; Van Doorn DPC; Potjewijd J; Van de Poll MCG; Van der Horst ICC; Damoiseaux JGMC; Spronk HMH; Cate HT; Reutelingsperger CP; Nagy M; Van Paassen P Haematologica; 2023 May; 108(5):1417-1422. PubMed ID: 36519327 [No Abstract] [Full Text] [Related]
31. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. von dem Borne PA; Meijers JC; Bouma BN Blood; 1995 Oct; 86(8):3035-42. PubMed ID: 7579397 [TBL] [Abstract][Full Text] [Related]
36. A recombinant fragment of von Willebrand factor reduces fibrin-rich microthrombi formation in mice with endotoxemia. Nguyen TC; Gushiken F; Correa JI; Dong JF; Dasgupta SK; Thiagarajan P; Cruz MA Thromb Res; 2015 May; 135(5):1025-30. PubMed ID: 25769494 [TBL] [Abstract][Full Text] [Related]
37. Multiple ligands of von Willebrand factor-binding protein (vWbp) promote Staphylococcus aureus clot formation in human plasma. Thomer L; Schneewind O; Missiakas D J Biol Chem; 2013 Sep; 288(39):28283-92. PubMed ID: 23960083 [TBL] [Abstract][Full Text] [Related]
38. von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain. Hill-Eubanks DC; Lollar P J Biol Chem; 1990 Oct; 265(29):17854-8. PubMed ID: 2120219 [TBL] [Abstract][Full Text] [Related]
39. A novel protein C-factor VII chimera provides new insights into the structural requirements for cytoprotective protease-activated receptor 1 signaling. Gleeson EM; McDonnell CJ; Soule EE; Willis Fox O; Rushe H; Rehill A; Smith OP; O'Donnell JS; Preston RJS J Thromb Haemost; 2017 Nov; 15(11):2198-2207. PubMed ID: 28834159 [TBL] [Abstract][Full Text] [Related]